Relative hypoleptinemia in patients with type 1 and type 2 diabetes mellitus

International Journal of Obesity

Volumn 24, Issue 8, 2000, Pages 976-981

  Roden, M ^a   Ludwig, C ^a   Nowotny, P ^a   Schneider, B ^a   Clodi, M ^a   Vierhapper, H ^a   Roden, A ^a   Waldhausl W ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Cholesterol; Diabetes mellitus; Human; Leptin; Obesity; Triglycerides

Indexed keywords

CHOLESTEROL; GLYCOSYLATED HEMOGLOBIN; LEPTIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION FUNCTION; FEMALE; HORMONE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0033867974     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0801266     Document Type: Article

References (42)

1. 1 Pelleymounter M, Cullen M, Baker M, Hecht R, Winters D, Boone T, Collins F. Effects of the ob gene product on body weight regulation in ob/ob mice. Science 1995; 269: 540-543.
2. 2 Chen H, Charlat O, Tartaglia LA, Woolf EA, Wang X, Ellis SJ, Lakey ND, Culpepper J, Moore KJ, Bretbart RE, Duyk GM, Tepper RI, Morgenstern JP. Evidence that the diabetic gene encodes the leptin receptor; identification of a mutation in the leptin receptor gene in db/db mice. Cell 1996; 84: 491 495.
3. 3 Caro JF, Sinha MK, Kolaczynski JW, Zhang PL, Considine RV. Leptin: the tale of an obesity gene. Diabetes 1996; 45: 1455-1462.
4. 4 Considine RV, Considine EL, William CJ, Nyce MR, Zhang P, Opentanova I, Ohannesian JP, Kolaczynski JW, Bauer TL, Moore JH, Caro JF. Mutation screening and identification of a sequence variation in the human ob gene coding. Biochem Biophys Res Commun 1996; 220: 735-739.
5. 5 Montague CT, Prins JB, Sanders L, Digby JE, O'Rahilly S. Depot and sex specific differences in human leptin mRNA expression: implications for the control of regional fat distribution. Diabetes 1997; 46: 342-347.
6. 6 Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL, Caro J. Serum immunoreactive leptin concentrations in normalweight and obese humans. N Engl J Med 1996; 334: 292-295.
7. 7 Kennedy A, Gettys TW, Watson P, Wallace P, Ganaway E, Pan Q, Garvey WT. The metabolic significance of leptin in humans: gender-based differences in relationship to adiposity, insulin sensitivity and energy expenditure. J Clin Endocr Metab 1997; 82: 1293-1300.
8. 8 Reaven GM. Role of insulin resistance in human disease, Banting lecture 1988. Diabetes 1988; 37: 1595-1607.
9. 9 Kiefer TJ, Heller RS, Leech CA, Holz GG, Habener JF. Leptin suppression of insulin secretion by the activation of ATP-sensitive K channels in pancreatic beta cells. Diabetes 1997; 46: 1087-1093.
10. 10 Shimabukuro M, Koyama K, Chen G, Wang M-Y, Trieu F, Lee Y, Newgard CB, Unger RH. Direct antidiabetic effect of leptin through triglyceride depletion of tissues. Proc Natl Acad Sci USA 1997; 94: 4637-4641.
11. 11 Nemecz M, Preininger K, Englisch R, Fürnsinn C, Schneider B, Waldhäusl W, Roden M. Acute effect of leptin on hepatic glycogenolysis and gluconeogenesis in perfused liver. Hepatology 1999; 29: 166-172.
12. 12 Müller G, Ertl J, Gerl M, Preibisch G. Leptin impairs metabolic actions of insulin in isolated rat adipocytes. J Biol Chem 1997; 272: 10585-10593.
13. 13 Wabitsch M, Jensen PB, Blum WF, Chrostoffersen CT, Englaro P, Heinze E, Rascher W, Teller W, Tornqvist H, Hauner H. Insulin and cortisol promote leptin production in cultured human fat cells. Diabetes 1996; 45: 1435-1438.
14. 14 Segal KR, Landt M, Klein S. Relationship between insulin sensitivity and plasma leptin concentration in lean and obese men. Diabetes 1996; 45: 988-991.
15. 15 Kautzky-Willer A, Ludwig C, Nowotny P, Roden A, Huemer C, Widhalm F. Vierhapper H, Waldhäusl W, Roden M. Elevation of plasma leptin concentrations in obese hyperinsulinemic hypothyroidism before and after treatment. Eur J Clin Invest 1999; 29: 395-403.
16. 16 Turpeinen AK, Haffner SM, Louheranta AM, Niskanen LK, Miettinen H, Uusitupa MIJ. Serum leptin in subjects with impaired glucose tolerance in relation to insulin sensitvity and first-phase insulin response. Int J Obes 1997; 21: 284-287.
17. 17 Haffner S, Stern M, Miettinen H, Ming W, Gingerich R. Leptin concentrations in diabetic and nondiabetic Mexican-Americans. Diabetes 1996; 45: 822-824.
18. 18 Mantzoros CS, Dunaif A, Flier JS. Leptin concentrations in the polycystic ovary syndrome. J Clin Endocr Melcib 1997; 82: 1687-1691.
19. 19 Laughlin GA, Yen SSC. Hypoleptinemia in women athletes: absence of a diurnal rhythm with amenorrhea. J Clin Endocr Metab 1997; 82: 318-321.
20. 20 Dagogo-Jack S, Fanelli C, Paramore D, Brothers J, Landt M. Plasma leptin and insulin relationships in obese and nonobese humans. Diabetes 1996; 45: 695-698.
21. 21 Pratley RE, Nicolson M, Bogardus C, Ravussin E. Effects of acute hyperinsulinemia on plasma leptin concentrations in insulin-sensitive and insulin-resistant Pima Indians. J Clin Endocr Metab 1996; 81: 4418-4421.
22. 22 Ryan AS, Elahi D. The effects of acute hyperglycemia and hyperinsulinemia on plasma leptin levels: its relationships with body fat, visceral obesity, and age in women. J Clin Endocr Metab 1996; 81: 4433-4438.
23. 23 Sinha MK, Ohannesian JP, Heiman ML, Kriaueiunas A, Stephens TW, Magosin S, Marco C, Caro JF. Nocturnal rise of leptin in lean, obese, and non-insulin dependent diabetes mellitus subjects. J Clin Invest 1996; 97: 1344-1347.
24. 24 Shimizu H, Kakizaki S, Tsuchiya T, Nagamine T, Takagi H, Takayama H, Kobayashi I, Mori M. An increase of circulating leptin in patients with liver cirrhosis. Int J Obes 1998; 22: 1234-1238.
25. 25 Widjaja A, Stratton I, Horn R, Holman R, Turner R, Brabant G. UKPDS: plasma leptin, obesity and plasma insulin in type 2 diabetic subjects. J Clin Endocr Metab 1996; 82: 654-658.
26. 26 Kristensen K, Pedersen SB, Fisker S, Norrelund H, Rosenfalck AM, Jøgensen JOL, Richelsen B. Serum leptin levels and leptin expression in growth hormone (GH)-deficient and healthy adults: influence of GH treatment, gender, and fasting. Metabolism 1998; 47: 1514-1519.
27. 27 Ostlund RE, Yang JW, Klein S, Gingerich R. Relation between plasma leptin concentration and body fat, gender, diet, age and metabolic covariates. J Clin Endocr Metab 1996; 81: 3909-3913.
28. 28 Moller N, O'Brien P, Nair KS. Disruption of the relationship between fat content and leptin levels with aging in humans. J Clin Endocr Metab 1998; 83: 931-934.
29. 29 Beck-Nielsen H. Groop LC. Metabolic and genetic characterization of prediabetic states. Sequence of events leading to non-insulin-dependent diabetes mellitus. J Clin Invest 1994; 94: 1714-1721.
30. 30 Larsson H, Elmstahl S, Ahren B. Plasma leptin levels correlate to islet function independently of body fat in postmenopausal women. Diabetes 1996; 45: 1580-1584.
31. 31 Clement K, Lahlou N, Ruiz J, Hager J, Bougneres P, Basdevant A, Guygrand B, Froguel P. Association of poorly controlled diabetes with low serum leptin in morbid obesity. Int J Obes 1997; 21: 556-561.
32. 32 Malmstrom R, Taskinen M, Karonen S, Yki-Jarvinen H. Insulin increases plasma leptin concentrations in normal subjects and patients with NIDDM. Diabetologia 1996; 39: 993-996.
33. 33 Kolaczynski JW, Nyce MR, Considine RV, Boden G, Nolan JJ, Henry RR, Mudaliar SR, Olefsky J, Caro JF. Acute and chronic effect of insulin on leptin production in humans, Diabetes 1996; 40: 699-701.
34. 34 O'Meara NM, Sturis J, Van Cauter E, Polonsky KS. Lack of control by glucose of ultradian insulin secretory oscillations in impaired glucose tolerance and in non-insulin-dependent diabetes mellitus. J Clin Invest 1993; 92: 262-271.
35. 35 Schmitz O, Fisker S, Ørskov L, Hove KY, Nyholm B, Moller N. Effects of hyperinsulinemia and hypoglycemia on circulating leptin levels in healthy lean males. Diabetes Metab 1997; 23: 80-83.
36. 36 Nolan JJ, Olefsky JM, Nyce MR, Considine RV, Caro JF. Effect of troglitazone on leptin production: studies in vitro and in human subjects. Diabetes 1996; 45: 1276-1278.
37. 37 Tritos NA, Mantzoros CS. Leptin: its role in obesity and beyond. Diabetologia 1997; 40: 1371-1379.
38. 38 Meyer C, Robson D, Rackovsky N, Nadkarni V, Gerich J. Role of kidney in human leptin metabolism. Am J Physiol 1997; 273: E903-E907.
39. 39 Rainwater DL, Comuzzie AG, VandeBerg JL, Mahaney MC, Blangero J. Serum leptin levels are independently correlated with two measures of HDL. Atherosclerosis 1997; 132: 237-243.
40. 40 Unger RH. Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications. Diabetes 1995; 44: 863-870.
41. 41 Roden M, Price TB, Perseghin G, Falk-Petersen K, Cline GW, Rothman DL, Shulman GI. Mechanism of free fatty acid induced insulin resistance in humans. J Clin Invest 1996; 97: 2859-2865.
42. 42 Peinò R, Fernández Alvarez J, Penàlva A, Considine RV, Rodriguez-Segade S, Rodriguez-Garcia J, Cordido F, Casanueva FF, Dieguez C. Acute changes in free-fatty acids (FFA) do not alter serum leptin levels. J Endocr Invest 1998; 21: 526-530.